• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acasti Pharma (NQ: ACST )

3.370 UNCHANGED
Last Price Updated: 3:44 PM EDT, Oct 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.370
Bid (Size) 3.320 (5)
Ask (Size) 3.450 (39)
Prev. Close 3.370
Today's Range 3.370 - 3.370
52wk Range 1.980 - 3.600
Shares Outstanding 44,612,831
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
September 20, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
September 16, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire

Performance

YTD
+22.10%
+22.10%
1 Month
+12.33%
+12.33%
3 Month
+34.26%
+34.26%
6 Month
+14.24%
+14.24%
1 Year
+40.42%
+40.42%

More News

Read More
Recap: Acasti Pharma Q4 Earnings
June 23, 2023
Via Benzinga
Acasti Pharma's Earnings Outlook
February 13, 2023
Via Benzinga
ACST Stock Earnings: Acasti Pharma Beats EPS for Q1 2025
August 09, 2024
Via InvestorPlace
ACST Stock Earnings: Acasti Pharma Beats EPS for Q4 2024
June 21, 2024
Via InvestorPlace
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024
June 18, 2024
Via InvestorPlace
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
May 23, 2024
Via InvestorPlace
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 26, 2023
Via Benzinga
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 18, 2024
Via Benzinga
Why Acasti Pharma (ACST) Stock Is Exploding Higher
September 26, 2023
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 09, 2023
Via InvestorPlace
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 05, 2023
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 22, 2023
Via InvestorPlace
Acasti Pharma Reports Third Quarter 2023 Operational Results
February 14, 2023
From Acasti Pharma, Inc.
Via GlobeNewswire
Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule
January 25, 2023
From Acasti Pharma, Inc.
Via GlobeNewswire
Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31
January 24, 2023
From Acasti Pharma, Inc.
Via GlobeNewswire
Earnings Scheduled For February 14, 2023
February 14, 2023
Via Benzinga
Acasti Pharma Discusses Positive Clinical Study Results for GTX-101 and GTX-102 and Upcoming Phase 3 Study for GTX-104 with The Stock Day Podcast
January 17, 2023
Via Newsfile
Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18
January 13, 2023
From Acasti Pharma, Inc.
Via GlobeNewswire
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
January 06, 2023
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 06, 2023
Via InvestorPlace
Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures
January 05, 2023
From Acasti Pharma, Inc.
Via GlobeNewswire
Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia
December 28, 2022
From Acasti Pharma, Inc.
Via GlobeNewswire
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
December 23, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap